EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway
Advanced Science · 2026
DOI: 10.1002/advs.202522826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Liyun Huo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Nucleotidyltransferases, Membrane Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, National Key Research And Development Plan.
Abstract (Originalsprache)
The efficacy of immunotherapy in colorectal cancer (CRC) is frequently limited by an immunosuppressive tumor microenvironment. Here, we identify exonuclease/endonuclease/phosphatase domain‐containing protein 1 (EEPD1), a gatekeeper of homologous recombination (HR) repair, as a key driver of this immune exclusion. Downregulation of EEPD1 profoundly compromises HR in CRC cells, which curtails their proliferative and metastatic capacities in vitro and in vivo. Mechanistically, EEPD1 deficiency fuels genomic instability, leading to cytosolic DNA accumulation and activation of the cGAS‐STING‐type I interferon axis. This cascade promotes dendritic cell maturation, skews macrophages toward a proinflammatory M1 phenotype, and enhances tumor‐associated antigen presentation, culminating in robust CD8 + T cell activation and cytotoxicity. Our findings elucidate a direct mechanism by which targeting EEPD1 sensitizes CRC to anti‐PD1 immunotherapy. Our work establishes EEPD1 as a promising therapeutic target to overcome immune checkpoint blockade resistance in colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- The Core Facilities for Medical Science at Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Department of Microbiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
- Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Gastrointestinal Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
ORCID-Profile: Liyun Huo, Tianyu Tao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- National Key Research And Development Plan
- Guangdong Science and Technology Planning Program
- Fujian Provincial Health and Medical High-Level Talent Team
- Key Technologies R&D Program of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
- the Funding by Science and Technology Projects in Guangzhou
Zitieren
APA
Huo, L., Wu, C., Li, X., Ma, C., Huang, J., Chen, Z., He, W., Tao, T., & Zhang, W. (2026). EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway. Advanced Science. https://doi.org/10.1002/advs.202522826
Vancouver
Huo L, Wu C, Li X, Ma C, Huang J, Chen Z, et al. EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway. Advanced Science. 2026. doi:10.1002/advs.202522826
BibTeX
@article{Huo2026,
author = {Huo, Liyun and Wu, Chong and Li, Xiaobo and Ma, Caina and Huang, Jiamin and Chen, Zishuo and He, Weiling and Tao, Tianyu and Zhang, Weijing},
title = {EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202522826}
}
EUVIMED